RDY 612 (Pramipexole dihydrochloride extended-release 0.75 mg)
Pill imprint RDY 612 has been identified as Pramipexole dihydrochloride extended-release 0.75 mg.
Pramipexole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 0.75 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- RDY 612
- Strength:
- 0.75 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Dr. Reddy's Laboratories Limited
More about pramipexole
Consumer resources
- Other brands: Mirapex, Mirapex ER
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
